# Actavia Life Sciences, Inc. (RASP)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RASP/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2024 | $ 0 | $ -100.4K | $ -37.6K | $ 304.0K | $ -2.18M |
| 2023 | $ 0 | $ -4.80M | $ -58.8K | $ 225.7K | $ -2.10M |
| 2022 | $ 0 | $ -627.3K | $ -267.3K | $ 227.2K | $ -1.81M |
| 2021 | $ 0 | $ -1.06M | $ -377.1K | $ 393.6K | $ -2.50M |
| 2020 | $ 0 | $ -6.83M | $ -283.8K | $ 579.4K | $ -2.83M |
| 2019 | $ 0 | $ -894.7K | $ -149.5K | $ 331.2K | $ 2.43M |
| 2018 | $ 0 | $ -3.64M | $ -7.27M | $ 235.0K | $ 2.83M |
| 2017 | $ 0 | $ -8.07M | $ -5.56M | $ 0 | $ 5.04M |
| 2016 | $ 0 | $ -3.72M | $ -1.15M | $ 0 | $ 5.77M |
| 2015 | $ 0 | $ -20.9K | $ -11.7K | $ 10.2K | $ -16.3K |
| 2014 | $ 0 | $ -36.0K | $ -36.9K | $ 0 | $ -1.4K |
| 2013 | $ 0 | $ -37.0K | $ -30.4K | $ 0 | $ 24.1K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.14 |
| Liabilities / Eq | -1.02 |
| Current Ratio | 0.02 |

## Other views

- [Metrics](https://sponda.capital/en/RASP.md)
- [Charts](https://sponda.capital/en/RASP/charts.md)
- [Compare](https://sponda.capital/en/RASP/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.